Oppenheimer initiates its coverage on Mako Surgical (MAKO +1.1%) with a tepid Neutral rating on...

|About: MAKO Surgical Corp. (MAKO)|By:, SA News Editor

Oppenheimer initiates its coverage on Mako Surgical (MAKO +1.1%) with a tepid Neutral rating on its view that the current valuation on the stock already factors in the buzz over its results with its partial-knee replacement product and the rollout of a new application. Shares +66.1% YTD.